Inefficient markets create inefficient outcomes. As Managing Editor, Wayne Winegarden, explains in his latest Forbes editorial, the pharmaceutical market is rife with inefficiencies. Until reforms that improve the efficiency of the pharmaceutical market are implemented, adverse outcomes will persist. The entire editorial can be read here.

Leave a Reply

Your email address will not be published. Required fields are marked *